Tezepelumab for Patients with Severe Uncontrolled Asthma: A Systematic Review and Meta-Analysis

Tezepelumab is a human monoclonal antibody that blocks thymic stromal lymphopoietin, an epithelial-cell-derived cytokine implicated in the pathogenesis of asthma. It was approved by the United States Federal Drug Administration (US FDA) as an add-on maintenance treatment for patients with severe unc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zoumot, Zaid, Al Busaidi, Nasser, Tashkandi, Wail, Aljohaney, Ahmed A, Isse, Said, Vidyasagar, Kota, Ukwaja, Kingsley Nnanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680989/
https://www.ncbi.nlm.nih.gov/pubmed/36425526
http://dx.doi.org/10.2147/JAA.S378062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680989/
https://www.ncbi.nlm.nih.gov/pubmed/36425526
http://dx.doi.org/10.2147/JAA.S378062

Ejemplares similares